EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies

Hanxiao Shi iD, Yiqian Feng, Tao Guo, Wenjun Shou, Yuandong Li

Breast Cancer: Targets and Therapy · 2026-06 · Volume 18 · 1-15

DOI: 10.2147/bctt.s612951 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-06. Verfasst von Hanxiao Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of the First Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

breast carcinomadrug resistancehuman epidermal growth factor receptor 2 heterogeneitytargeted therapy

Autor:innen und Institutionen

  • Department of the First Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  • Department of Occupational Health, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  • Department of Breast Surgery, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.

ORCID-Profile: Hanxiao Shi

Zitieren

APA

Shi, H., Feng, Y., Guo, T., Shou, W., & Li, Y. (2026). HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Breast Cancer: Targets and Therapy, Volume 18, 1-15. https://doi.org/10.2147/bctt.s612951

Vancouver

Shi H, Feng Y, Guo T, Shou W, Li Y. HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-15. doi:10.2147/bctt.s612951

BibTeX
@article{Shi2026,
  author = {Shi, Hanxiao and Feng, Yiqian and Guo, Tao and Shou, Wenjun and Li, Yuandong},
  title = {HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--15},
  doi = {10.2147/bctt.s612951}
}
Kostenlos starten →